Serg Zastavkin /
7 July 2015Americas

Biogen signs ‘$1bn’ deal to make eye treatments

Biotechnology company Biogen has agreed a partnership potentially worth $1 billion with gene therapy business AGTC to develop eye treatments.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at